Dr. Baidal completed Internal Medicine Residency at Jackson Memorial Hospital, University of Miami in 2012. This was followed by a clinical and research fellowship in Endocrinology, Diabetes and Metabolism at BIDMC, Harvard Medical School, in 2015. After completion of his fellowship training, he returned to the Diabetes Research Institute, University of Miami. In his current faculty position, Dr. Baidal is the Center Director for Type 1 Diabetes TrialNet at the University of Miami and a member of the NIDDK funded Collaborative Islet Transplantation Registry Steering Committee and Co-Chair of the Data Elements Committee. Dr. Baidal serves as PI/Co-PI in multiple T1D clinical trials including pancreatic beta cell replacement strategies, TrialNet prevention trials and early intervention trials testing drug and cell therapies aimed at preventing loss of ß-cell function. His clinical focus centers on the management of T1D and type 2 diabetes and the use of advanced diabetes technologies including continuous glucose monitoring devices, smart insulin pens, and hybrid closed loop systems.

Dr. Carlos Blaschke is a Research Assistant Professor in the Division of Endocrinology, Diabetes & Metabolism at the University of Miami Miller School of Medicine and the Director of Clinical Research at the Diabetes Research Institute (DRI). His academic and professional journey has been devoted to advancing type 1 diabetes (T1D) research through innovative and interdisciplinary approaches. Trained in both medicine and clinical research, he began his career in Colombia, earning his MD before joining the University of Miami. Starting as a student in the Thyroid Endocrine Research Laboratory, Dr. Blaschke progressed to become Director of Clinical Research at the DRI. He has extensive experience in the conduct and coordination of multiple type 1 diabetes research projects, including the NIH-funded Type 1 Diabetes TrialNet program at the University of Miami. He currently serves as a Co-Investigator on several clinical trials focused on the prevention, delay, and intervention of T1D. Mentoring and education have been key aspects of his career. He has trained research nurses in essential clinical research procedures, including metabolic testing, and has been an invited speaker at both national and international scientific forums. Beyond his research, Dr. Blaschke is actively involved in community outreach and advocacy efforts. He serves as a Board Member of the Southeast Florida Chapter of Breakthrough T1D (formerly JDRF), helping advance awareness, advocacy, fundraising, and support initiatives for individuals and families affected by type 1 diabetes. His participation in ADA and Breakthrough T1D walks, autoantibody screening and detection initiatives, and educational programs at diabetes camps underscores his commitment to public health, early detection, and the prevention of type 1 diabetes. Through his leadership in clinical research, education, and community engagement, Dr. Blaschke remains dedicated to improving outcomes for individuals living with or at risk for type 1 diabetes.

Dr. Janine Sanchez is Professor of Clinical Pediatrics and Director of Pediatric Diabetes at University of Miami. She has been involved in variety of diabetes research projects for over 30 years. She is a member of the Type 1 Exchange clinical leadership team.